Sodium-glucose Cotransporter-2 Inhibitors in Heart Failure: Mechanisms and Clinical Applications: A Machine-Generated Literature Overview

Mukesh Nandave
Skip to product information

Sodium-glucose Cotransporter-2 Inhibitors in Heart Failure: Mechanisms and Clinical Applications: A Machine-Generated Literature Overview

Mukesh Nandave
Release date:
Paperback
Regular price $291.95
Sale price $291.95 Regular price $0.00
Final Sale. No returns or exchanges.
Oversized: This item will be shipped by appointment through our delivery partner.
Overweight: This item will be shipped by appointment through our delivery partner.

Digital download

Immediate access in your Kobo library

Deliver to

Notify me when back in stock

Buy online, pick up at Bay & Floor

Out of stock

Find it in store

Out of stock

Found in: Health, Medical Reference

Earn 1460 plum points and save more with plum Rewards. Learn more

View full details

Overview

528 PAGESENGLISH

Promotional Details

Overall rating: 0.0 / 5 from 0 reviews.

AI Generated Review Summary

Summary topics

Review topics: [].

Review highlights

Reviews

Q&A

  • Published date: Nov 16, 2025
  • Language: English
  • No. of Pages: 528
  • Publisher: Springer Nature
  • ISBN: 9789819775705
  • Dimensions: 6.1" W x 1.0" L x 9.25" H

Dr. Mukesh Nandave is an In-charge Director of the School of Pharmaceutical Sciences, Associate Dean (Research), and head of the Department of Pharmacology and Pharmaceutical Biotechnology at Delhi Pharmaceutical Sciences and Research University, Govt. of NCT of Delhi, New Delhi, India. He has earlier served as associate professor and head of the Department of Pharmacology at NMIMS University, Mumbai (2010-2017). He has also worked as a research scientist in the Medical Affairs and Clinical Research Department of Ranbaxy Research Laboratories (currently known as Sun Pharmaceutical Industries Limited, Gurugram). Dr. Nandave earned his Ph. D. in pharmacology from AIIMS, Delhi, and received his post-doctoral training from the Division of Cardiothoracic Surgery, the Ohio State University Medical Center, Columbus, USA.

For more than 20 years, Dr. Nandave has investigated the role of nutraceuticals, herbomineral formulations, and phytoconstituents for myocardial ischemia & reperfusion injury, diabetes, obesity, and pain management. His lab received more than 3.5 crore total funding from Govt. (DBT, DST, ICMR, and AYUSH) as well as industry (Pharmazz, Dabur, Fertis India, Charak Pharma, Madhavbaug, and Sandu Pharma). He has published over 100 papers in peer-reviewed national and international journals, books, and book chapters.

Dr. Nandave has received numerous awards including the Distinguished Leadership Award of the International Academy of Cardiovascular Sciences; Prof. S. C. Lahiri Oration and G. Achari Gold Medal by the Indian Pharmacological Society; Association of Pharmaceutical Teachers of India (APTI) Young Pharmacy Teacher of the Year Award, Early Investigator Award by International Society for Heart Research, Prof. Duggirala Visweswaram & Prof. Sreemantula Satyanarayana Prize; Best Research Output of the Year for 2014-2015, 2013-2014, and 2012-2013 Award" of SVKM's NMIMS University.

Dr. Nandave is secretary general, of the International Academy of Cardiovascular Sciences (IACS)-India section and treasurer of the Society for Promotion and Research of Cardiovascular Sciences (SPARCS). He is a life member of various professional bodies including the International Society for Heart Research (ISHR), the International Academy of Cardiovascular Sciences (IACS); the Indian Pharmacological Society (IPS); the Indian Pharmaceutical Association (IPA); the Association of Physiologist and Pharmacologist of India (APPI); Association of Pharmaceutical Teachers of India (APTI); and Society for Ethnopharmacology. 

 

Recently Viewed